About Satellite Bio
Satellite Bio is a company based in Cambridge (United States) founded in 2019 by Arnav Chhabra and Christopher Chen. Satellite Bio has raised $110 million across 2 funding rounds from investors including Lightspeed Venture Partners, aMoon and Polaris Partners. The company has 21 employees as of December 31, 2021. Satellite Bio offers products and services including SAT Platform and Tissue Therapeutics. Satellite Bio operates in a competitive market with competitors including KaloCyte, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others.
- Headquarter Cambridge, United States
- Employees 21 as on 31 Dec, 2021
- Founders Arnav Chhabra, Christopher Chen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Satellite Biosciences Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$110 M (USD)
in 2 rounds
-
Latest Funding Round
$91 M (USD), Series A
Feb 25, 2022
-
Investors
Lightspeed Venture Partners
& 5 more
-
Employee Count
21
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Satellite Bio
Satellite Bio offers a comprehensive portfolio of products and services, including SAT Platform and Tissue Therapeutics.
Enables expansion and delivery of solid organ cells for regenerative therapies.
Delivers living cells to repair or replace organ functions like the liver.
People of Satellite Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Satellite Bio
Satellite Bio has successfully raised a total of $110M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $91 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Satellite Bio
Satellite Bio has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Lightspeed Venture Partners, aMoon and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Locked | Locked | Locked | |
|
Venture capital investments in healthcare are focused on by aMoon.
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked |
Investor details for Satellite Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Satellite Bio
Investment portfolio details for Satellite Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Satellite Bio
Detailed financials for Satellite Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Satellite Bio Comparisons
Peer comparison for Satellite Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Satellite Bio
Satellite Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KaloCyte, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotechnology-based red blood cell substitutes are developed.
|
|
| Locked | Locked | Locked |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
|
| Locked | Locked | Locked |
Cell-based skin substitutes are developed for therapeutic and research uses.
|
|
| Locked | Locked | Locked |
Engineered liver tissues are developed for liver disease treatments.
|
|
| Locked | Locked | Locked |
Tissue engineering technologies for cardiovascular regenerative surgeries are developed.
|
Detailed competitors of Satellite Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Satellite Bio
Complete news archive for Satellite Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satellite Bio
Satellite Bio was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Satellite Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Satellite Bio is a funded company, having raised a total of $110M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Satellite Bio is 21.
Satellite Bio was founded in 2019 in Cambridge, United States, and operates in the regenerative medicine sector. Proprietary implantable satellite organs are developed through synthetic biology and tissue engineering to support living therapeutic solutions. Hydrogel grafts are created, and in vitro assays are conducted as part of cell therapy efforts. Focus is placed on advancing treatments in this field.
Satellite Bio's top competitors include KaloCyte, Stratatech Corp and Morphocell Technologies.
Satellite Bio offers SAT Platform and Tissue Therapeutics.
Satellite Bio has 6 investors. Key investors include Lightspeed Venture Partners, aMoon, Polaris Partners, Catalio Capital Management, and Waterman Ventures.